A Study to Investigate the Radiological Onset of Action After Treatment Initiation With Subcutaneous (SC) Natalizumab in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)
- Status
- TERMINATED
- Phase
- PHASE4
Clinical Trials Related to Biogen
Related studies linked through entity extraction aliases.
A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Longitudinal Data Collection in Pediatric and Adult Patients With Spinal Muscular Atrophy in Latin America
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Multiple Sclerosis Outcome Determination Evaluating Real Differences After TimE
- Status
- UNKNOWN
- Phase
- N/A
A Study to Assess if BIIB122 Tablets Are Safe and Can Slow Worsening of Early-Stage Parkinson's Disease in Participants With Specific LRRK2 Genetic Variants Between the Ages of 30 and 80 Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale
- Status
- TERMINATED
- Phase
- PHASE3
Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Multiple Sclerosis, at First Presentation (AttackMS)
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Virtual Reality for the Mitigation of Anxiety During Intrathecal Administration in Participants With Spinal Muscular Atrophy
- Status
- COMPLETED
- Phase
- NA
An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE3
A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
- Status
- TERMINATED
- Phase
- PHASE3
A Study for Tysabri Participant Preference
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of Natalizumab (BG00002) Administered Subcutaneously to Japanese Participants With Relapsing-Remitting Multiple Sclerosis
- Status
- TERMINATED
- Phase
- PHASE3
Tau Protein and SV2a Imaging in Patients With Tau Protein-related Diseases
- Status
- UNKNOWN
- Phase
- N/A
TOPIK Study: A Study to Report Progressive Multifocal Leukoencephalopathy and Other Serious Opportunistic Infections in Natalizumab Treated Participants
- Status
- COMPLETED
- Phase
- N/A
A Study to See How BIIB122 Works in the Human Body, and to Evaluate it's Safety, and Tolerability in Healthy Adult Japanese, Chinese, and Caucasian Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess the Pharmacokinetic (PK) Comparability of 2 Fixed Subcutaneous (SC) Doses of Aducanumab (BIIB037) With a Single, Weight-Based Intravenous (IV) Dose in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Safety of Exposure to Natalizumab During Pregnancy
- Status
- COMPLETED
- Phase
- N/A
Severe Acute Respiratory Syndrome Coronavirus Type 2 (SARS-CoV-2)-Related Multiple Sclerosis (MS) Vaccination Study
- Status
- TERMINATED
- Phase
- N/A
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics, With Target Occupancy Study of BIIB113 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1